Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Randomization was stratified according to country, sex (female, male) and per cent weight reduction at the end of lead-in ( 90% to demonstrate the superiority of tirzepatide MTD to placebo, for the coprimary endpoints, each at a two-sided significance level of 0.05
Tu SS et al
PlexusDx provides itemized receipts and medical documentation to support your FSA claim
Our compounds meet stringent purity standards for in vitro and in vivo laboratory protocols
US$ 29.32
US$ 20.84
US$ 28.80
US$ 22.94
